Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Autor: Sreenivasappa, Shylendra B, Catchatourian, R., Yim, Barbara *
Zdroj: In Blood 16 November 2008 112(11):4546-4546
Databáze: ScienceDirect